Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Atomoxetine Hydrochloride Versus Placebo in Taiwanese Children and Adolescents With ADHD

This study has been completed.
Information provided by:
Eli Lilly and Company Identifier:
First received: June 11, 2007
Last updated: NA
Last verified: June 2007
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2004
  Estimated Primary Completion Date: No date given
Publications automatically indexed to this study by Identifier (NCT Number):